The DOI matches its Crossref record.
Role of the Colchicine Ring A and Its Methoxy Groups in the Binding to Tubulin and Microtubule Inhibition
Abstract
The roles of the methoxy substituents on ring A of two ring colchicine (COL) analogues were probed by the synthesis of a number of drugs and the examination of their effect on binding to tubulin, inhibition of microtubule assembly, and induction of GTPase activity. Selective elimination of ring A methoxy groups at positions 2, 3, and 4 weakened all three processes. The effects on binding and inhibition were independent of the nature of ring C (or C'). Specifically, excision of the 2- or 3-methoxy groups weakened binding by ca. 0.4 kcal mol-1, while that of the 4-methoxy group of ring A was weakened by 1.36 +/- 0.15 kcal mol-1. The effect on the inhibition of microtubule assembly, expressed as the equilibrium constant for the binding of the tubulin-drug complex to the end of a microtubule, was more complex and strongly dependent on the nature of ring C (or C'). This was attributed to the abilities of various groups on ring C' to overcome the wobbling in the tubulin-drug complex introduced by the weakening of the anchoring provided by ring A. It is concluded that ring A of COL is not germane to the mechanism of the inhibition of tubulin self-assembly. It serves only as a complex-stabilizing anchor. The control of this process resides in the interactions that key oxygen atoms of ring C of COL or C' of structural analogues establish with the protein. It is proposed that the 4-methoxy group of ring A serves as a key attachment point for immobilization of the drugs on the protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the developed DDS is the most likely reason for enhanced tubulin inhibition because of the COL tubulin inhibitor agent [5,48,49].”
From Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles (2020) · cites this paper as [48]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 34
- Margolis R. L., 1977, Proc. Natl. Acad. Sci. U.S.A. 74, 3466−3470
- Skoufias D. A., 1992, Biochemistry 31, 738−746
- Pérez-Ramírez B., 1996, Biochemistry 35, 3277−3285
- David-Pfeuty T., 1977, Proc. Natl. Acad. Sci. U.S.A. 74, 5372−5376
- David-Pfeuty T., 1979, J. Biol. Chem., 254, 10.1016/S0021-9258(19)86539-0 · DOI
- Andreu J. M., 1981, Arch. Biochem. Biophys. 211, 151−157
- Pérez-Ramírez B., 1994, Biochemistry 33, 6253−6261
- Pérez-Ramírez B., 1998, Biochemistry 37, 1646−1661
- Medrano F. J., 1989, Biochemistry 28, 5589−5599
- Medrano F. J., 1991, Biochemistry 30, 3770−3777
- Andreu J. M., 1991, Biochemistry 30, 3777−3786
- Negishi, E., Takahashi, T., and King, A. O. (1988) inOrganic Syntheses(Heathcock, C. H., Ed.) Vol. 66, pp 67−74, Wiley, New York.
- Itoh Y., 1988, Helv. Chim. Acta, 72
- Beilsteins (1967) inHandbuch der Orgainschen Chemie, Vol. III6, p 6707, Springer-Verlag, Berlin.
- Noland, W. E. (1988)Organic Syntheses, Vol. VI, pp 407−411, Wiley, New York.
- Banwell M. G., 1991, Aust. J. Chem., 44
- Weisenberg R. C., 1968, Biochemistry 7, 4466−4479
- Lee J. C., 1973, J. Biol. Chem., 248
- Andreu J. M., 1984, Biochemistry 23, 1742−1752
- Andreu J. M., 1982, Biochemistry 21, 534−543
- Martens M. L., 1979, Anal. Biochem. 96, 448−455
- Press W. H., 1986, Numerical Recipes: the art of scientific computing
- Gaskin F., 1974, J. Mol. Biol., 89, 10.1016/0022-2836(74)90048-5 · DOI
- Lee J. C., 1977, Biochemistry 16, 1754−1764
- Bane S., 1984, J. Biol. Chem., 259, 10.1016/S0021-9258(17)42801-8 · DOI
- Pérez-Ramírez B., 1994, Biochemistry 33, 6262−6267
- Soto C., 1996, Biochemistry 35, 6337−6344
- Hastie S. B., 1991, Pharm. Ther. 51, 377−401
- Williams J. A., 1972, J. Cell. Biol., 54, 10.1083/jcb.54.1.157 · DOI
- Cortese F., 1977, J. Biol. Chem., 252, 10.1016/S0021-9258(17)40631-4 · DOI
- Rossi M., 1996, Biochemistry 35, 3286−3289
- Andreu J. M., 1982, Biochemistry 21, 6465−6476
- Diaz J. F., 1991, J. Biol. Chem., 266
- Abbreviations COL, colchicine
Cited by
Sorted by citations
AbouAitah, K., Hassan, H. A., Swiderska-Sroda, A., Gohar, L., Shaker, O. G., Wojnarowicz, J., Opalinska, A., Smalc-Koziorowska, J., Gierlotka, S., & Lojkowski, W. (2020) · Cancers · doi:10.3390/cancers12010144 · Cited by 105
Metadata
- Authors
- Andreu, J. M., Perez-Ramirez, B., Gorbunoff, M. J., Ayala, D., & Timasheff, S. N.
- Affiliations
- Department of Biochemistry, Brandeis University, 415 South Street, Waltham, Massachusetts 02254-9110, and Centro de Investigaciones Biológicas, CSIC, Velázquez 144, 28006 Madrid, Spain
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-05-22
- Volume
- 37
- Issue
- 23
- Pages
- 8356-8368
- ISSN
- 0006-2960
- 1520-4995
- Cited by
- 82
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review